Mimedx Group (MDXG)
Mimedx Group on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
9.4M
Short interest
settlement 2026-09-30
7.3
Days to cover
-3.5 days vs prior
56.8%
Short share of volume
2026-10-23
600
Fails to deliver
settlement 2026-09-18
Wed 28 Oct
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in MDXG is 9,362,899 shares, down 22,042 shares over the last month. Over the last 48 readings it ranged from 3,416,808 shares (29 November 2024) to 10,760,703 shares (15 September 2026). At the reported average volume of 1.3M shares a day that is 7.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/mdxg" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 9,362,899 | -13.0% | 1,273,880 | 7.35 |
| 2026-09-15 | 10,760,703 | +14.7% | 990,187 | 10.87 |
| 2026-08-31 | 9,384,941 | +5.5% | 989,713 | 9.48 |
| 2026-08-14 | 8,891,170 | +5.4% | 1,294,662 | 6.87 |
| 2026-07-31 | 8,434,992 | +12.1% | 1,585,077 | 5.32 |
| 2026-07-15 | 7,521,566 | -0.1% | 1,051,486 | 7.15 |
| 2026-06-30 | 7,527,408 | -2.3% | 1,613,499 | 4.67 |
| 2026-06-15 | 7,708,155 | +1.7% | 1,144,714 | 6.73 |
| 2026-05-29 | 7,578,242 | +3.8% | 1,479,617 | 5.12 |
| 2026-05-15 | 7,301,410 | -13.0% | 1,790,568 | 4.08 |
| 2026-04-30 | 8,389,116 | +12.7% | 2,235,221 | 3.75 |
| 2026-04-15 | 7,442,642 | -3.0% | 1,193,751 | 6.23 |
| 2026-03-31 | 7,668,857 | +24.1% | 1,217,031 | 6.30 |
| 2026-03-13 | 6,179,889 | -7.9% | 819,694 | 7.54 |
| 2026-02-27 | 6,709,725 | -8.0% | 946,382 | 7.09 |
| 2026-02-13 | 7,292,563 | +2.1% | 933,471 | 7.81 |
| 2026-01-30 | 7,139,877 | +12.7% | 1,069,042 | 6.68 |
| 2026-01-15 | 6,336,749 | +17.8% | 1,036,890 | 6.11 |
| 2025-12-31 | 5,378,136 | +16.9% | 774,860 | 6.94 |
| 2025-12-15 | 4,599,063 | +3.5% | 777,224 | 5.92 |
| 2025-11-28 | 4,444,405 | -5.1% | 766,025 | 5.80 |
| 2025-11-14 | 4,681,432 | +4.6% | 1,038,901 | 4.51 |
| 2025-10-31 | 4,474,566 | -6.8% | 1,113,888 | 4.02 |
| 2025-10-15 | 4,803,871 | +1.7% | 741,585 | 6.48 |
| 2025-09-30 | 4,724,384 | -0.6% | 658,815 | 7.17 |
| 2025-09-15 | 4,750,809 | -4.5% | 417,241 | 11.39 |
| 2025-08-29 | 4,975,900 | -0.9% | 443,850 | 11.21 |
| 2025-08-15 | 5,023,264 | +0.5% | 751,069 | 6.69 |
| 2025-07-31 | 4,999,921 | -9.4% | 985,961 | 5.07 |
| 2025-07-15 | 5,518,043 | +3.6% | 992,696 | 5.56 |
| 2025-06-30 | 5,327,652 | +6.6% | 716,629 | 7.43 |
| 2025-06-13 | 4,998,557 | -3.7% | 518,192 | 9.65 |
| 2025-05-30 | 5,189,565 | -3.0% | 574,841 | 9.03 |
| 2025-05-15 | 5,348,476 | +11.8% | 1,144,272 | 4.67 |
| 2025-04-30 | 4,783,676 | -1.1% | 463,571 | 10.32 |
| 2025-04-15 | 4,835,160 | +2.7% | 610,750 | 7.92 |
| 2025-03-31 | 4,708,892 | +13.4% | 511,120 | 9.21 |
| 2025-03-14 | 4,150,863 | +1.4% | 637,593 | 6.51 |
| 2025-02-28 | 4,092,683 | +10.1% | 603,677 | 6.78 |
| 2025-02-14 | 3,718,048 | -4.0% | 451,115 | 8.24 |
| 2025-01-31 | 3,871,981 | -13.3% | 559,563 | 6.92 |
| 2025-01-15 | 4,464,887 | -0.3% | 704,686 | 6.34 |
| 2024-12-31 | 4,476,346 | +16.2% | 693,161 | 6.46 |
| 2024-12-13 | 3,852,320 | +12.8% | 801,988 | 4.80 |
| 2024-11-29 | 3,416,808 | -3.0% | 861,903 | 3.96 |
| 2024-11-15 | 3,522,533 | -11.9% | 1,363,152 | 2.58 |
| 2024-10-31 | 4,000,033 | -0.7% | 486,990 | 8.21 |
| 2024-10-15 | 4,026,267 | -1.2% | 392,130 | 10.27 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of MDXG volume is 56.8%, up 17.8 points over the last five sessions. Over the last 30 readings it ranged from 25.4% (15 October 2026) to 70.2% (21 September 2026). The latest reading is 9.2 points above the 30-session average of 47.6%, on 455K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 258K | 455K | 56.8% | 7,174 |
| 2026-10-22 | 234K | 659K | 35.5% | 14,657 |
| 2026-10-21 | 512K | 856K | 59.8% | 6,060 |
| 2026-10-20 | 224K | 503K | 44.5% | 609 |
| 2026-10-19 | 461K | 1.2M | 39.5% | 6,749 |
| 2026-10-16 | 543K | 1.4M | 38.9% | 7,400 |
| 2026-10-15 | 126K | 495K | 25.4% | 100 |
| 2026-10-14 | 142K | 372K | 38.1% | 0 |
| 2026-10-13 | 100K | 270K | 37.0% | 72 |
| 2026-10-12 | 73K | 163K | 44.7% | 1,000 |
| 2026-10-09 | 41K | 100K | 41.0% | 0 |
| 2026-10-08 | 120K | 251K | 47.7% | 0 |
| 2026-10-07 | 94K | 333K | 28.1% | 44 |
| 2026-10-06 | 240K | 367K | 65.5% | 0 |
| 2026-10-05 | 125K | 341K | 36.5% | 0 |
| 2026-10-02 | 266K | 415K | 64.2% | 0 |
| 2026-10-01 | 199K | 389K | 51.2% | 0 |
| 2026-09-30 | 189K | 289K | 65.5% | 1,756 |
| 2026-09-29 | 135K | 217K | 62.2% | 0 |
| 2026-09-28 | 127K | 250K | 50.7% | 18 |
| 2026-09-25 | 225K | 535K | 42.0% | 100 |
| 2026-09-24 | 153K | 355K | 43.2% | 2 |
| 2026-09-23 | 248K | 367K | 67.5% | 133 |
| 2026-09-22 | 169K | 274K | 61.8% | 0 |
| 2026-09-21 | 216K | 307K | 70.2% | 11 |
| 2026-09-18 | 138K | 287K | 48.0% | 800 |
| 2026-09-17 | 157K | 391K | 40.2% | 11 |
| 2026-09-16 | 120K | 448K | 26.8% | 0 |
| 2026-09-15 | 149K | 370K | 40.3% | 0 |
| 2026-09-14 | 148K | 277K | 53.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 18 September 2026, the fails-to-deliver balance in MDXG is 600 shares, up 520 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (1 July 2026) to 751,372 shares (30 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-18 | 600 | $4.69 | $3K |
| 2026-09-16 | 80 | $4.72 | $378 |
| 2026-08-27 | 91 | $4.42 | $402 |
| 2026-08-24 | 41 | $4.33 | $178 |
| 2026-08-20 | 2,171 | $4.45 | $10K |
| 2026-08-14 | 9,490 | $4.20 | $40K |
| 2026-08-07 | 28,164 | $4.18 | $118K |
| 2026-07-31 | 9,374 | $4.27 | $40K |
| 2026-07-21 | 1,255 | $4.33 | $5K |
| 2026-07-16 | 780 | $4.27 | $3K |
| 2026-07-07 | 190 | $4.07 | $773 |
| 2026-07-01 | 1 | $3.85 | $4 |
| 2026-06-30 | 50,241 | $3.91 | $196K |
| 2026-06-29 | 126,651 | $3.93 | $498K |
| 2026-06-16 | 2,534 | $3.68 | $9K |
| 2026-06-15 | 1,050 | $3.60 | $4K |
| 2026-06-11 | 360 | $3.64 | $1K |
| 2026-06-10 | 5 | $3.71 | $19 |
| 2026-05-20 | 1,275 | $3.64 | $5K |
| 2026-05-05 | 3,537 | $3.61 | $13K |
| 2026-04-30 | 751,372 | $3.09 | $2.3M |
| 2026-04-23 | 149 | $3.31 | $493 |
| 2026-04-20 | 3,981 | $3.42 | $14K |
| 2026-04-06 | 588 | $3.92 | $2K |
| 2026-04-01 | 253,964 | $3.95 | $1.0M |
| 2026-02-03 | 881 | $5.09 | $4K |
| 2026-02-02 | 881 | $5.11 | $5K |
| 2026-01-20 | 492 | $5.42 | $3K |
| 2026-01-08 | 73 | $6.44 | $470 |
| 2026-01-07 | 142 | $6.40 | $909 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for MDXG in the last 90 days. The most recent filings are listed below. Latest filing: DOUG RICE (Chief Financial Officer) on 2026-07-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | DOUG RICE | Chief Financial Officer | Tax withholding | 13K | $3.95 | $50K | 400K |
| 2026-06-24 | Maersk-Moller Kimberly | Chief Commercial Officer | Tax withholding | 20K | $3.83 | $76K | 310K |
| 2026-06-10 | Olson Tiffany | Director | Grant | 51K | $3.64 | $185K | 109K |
| 2026-06-10 | HAWKINS WILLIAM A | Director | Grant | 51K | $3.64 | $185K | 255K |
| 2026-06-10 | Newton Todd | Director | Grant | 51K | $3.64 | $185K | 464K |
| 2026-06-10 | PUHY DOROTHY E | Director | Grant | 51K | $3.64 | $185K | 109K |
| 2026-06-10 | BIERMAN JAMES L | Director | Grant | 51K | $3.64 | $185K | 264K |
| 2026-03-13 | Maersk-Moller Kimberly | Chief Commercial Officer | Tax withholding | 7K | $4.38 | $30K | 329K |
| 2026-03-13 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 20K | $4.38 | $89K | 543K |
| 2026-03-10 | Maersk-Moller Kimberly | Chief Commercial Officer | Tax withholding | 21K | $4.50 | $96K | 336K |
| 2026-03-10 | Maersk-Moller Kimberly | Chief Commercial Officer | Exercise or conversion | 43K | $4.50 | $193K | 357K |
| 2026-03-10 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 61K | $4.50 | $277K | 563K |
| 2026-03-10 | Hulse William Frank IV | General Counsel and CAO | Exercise or conversion | 136K | $4.50 | $614K | 625K |
| 2026-03-10 | DOUG RICE | Chief Financial Officer | Tax withholding | 96K | $4.50 | $434K | 412K |
| 2026-03-10 | DOUG RICE | Chief Financial Officer | Exercise or conversion | 243K | $4.50 | $1.1M | 509K |
| 2026-03-04 | Maersk-Moller Kimberly | Chief Commercial Officer | Grant | 74K | $0.00 | $0 | 315K |
| 2026-03-04 | Whitlow Ricci S | Chief Operating Officer | Grant | 74K | $0.00 | $0 | 463K |
| 2026-03-04 | Hulse William Frank IV | General Counsel and CAO | Grant | 75K | $0.00 | $0 | 489K |
| 2026-03-04 | DOUG RICE | Chief Financial Officer | Grant | 74K | $0.00 | $0 | 266K |
| 2026-03-04 | Capper Joseph H | Chief Executive Officer | Grant | 371K | $0.00 | $0 | 905K |
| 2026-02-13 | Whitlow Ricci S | Chief Operating Officer | Tax withholding | 62K | $5.12 | $317K | 389K |
| 2025-11-06 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 58K | $7.42 | $432K | 237K |
| 2025-07-03 | DOUG RICE | Chief Financial Officer | Tax withholding | 13K | $6.34 | $81K | 188K |
| 2025-06-24 | Maersk-Moller Kimberly | Chief Commercial Officer | Tax withholding | 12K | $5.96 | $72K | 295K |
| 2025-06-18 | Olson Tiffany | Director | Grant | 29K | $6.47 | $185K | 58K |
| 2025-06-18 | PUHY DOROTHY E | Director | Grant | 29K | $6.47 | $185K | 58K |
| 2025-06-18 | LAURENCIN CATO T | Director | Grant | 29K | $6.47 | $185K | 182K |
| 2025-06-18 | HAWKINS WILLIAM A | Director | Grant | 29K | $6.47 | $185K | 204K |
| 2025-06-18 | BIERMAN JAMES L | Director | Grant | 29K | $6.47 | $185K | 213K |
| 2025-06-18 | BEHRENS M KATHLEEN | Director | Grant | 29K | $6.47 | $185K | 213K |
| 2025-05-08 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $7.42 | $66K | 414K |
| 2025-05-02 | Capper Joseph H | Chief Executive Officer | Buy | 200K | $6.34 | $1.3M | 530K |
| 2025-04-23 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $6.76 | $60K | 422K |
| 2025-04-08 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $6.86 | $61K | 431K |
| 2025-04-01 | Maersk-Moller Kimberly | Chief Commercial Officer | Tax withholding | 2K | $7.50 | $13K | 307K |
| 2025-03-17 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 2K | $8.04 | $14K | 309K |
| 2025-03-13 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 4K | $7.89 | $32K | 311K |
| 2025-03-13 | Hulse William Frank IV | General Counsel and CAO | Sell | 20K | $7.89 | $161K | 440K |
| 2025-03-13 | Hulse William Frank IV | General Counsel and CAO | Sell | 34K | $7.89 | $270K | 461K |
| 2025-03-10 | Hulse William Frank IV | General Counsel and CAO | Sell | 81K | $7.80 | $635K | 495K |
| 2025-03-03 | Capper Joseph H | Chief Executive Officer | Grant | 223K | $0.00 | $0 | 330K |
| 2025-03-03 | DOUG RICE | Chief Financial Officer | Grant | 46K | $0.00 | $0 | 201K |
| 2025-03-03 | Hulse William Frank IV | General Counsel and CAO | Grant | 77K | $0.00 | $0 | 530K |
| 2025-03-03 | Hulse William Frank IV | General Counsel and CAO | Grant | 46K | $0.00 | $0 | 576K |
| 2025-03-03 | Whitlow Ricci S | Chief Operating Officer | Grant | 46K | $0.00 | $0 | 449K |
| 2025-03-03 | Maersk-Moller Kimberly | Chief Commercial Officer | Grant | 46K | $0.00 | $0 | 315K |
| 2025-02-28 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 2K | $8.41 | $18K | 265K |
| 2025-02-13 | Whitlow Ricci S | Chief Operating Officer | Sell | 61K | $8.28 | $509K | 403K |
| 2024-12-11 | Maersk-Moller Kimberly | Chief Commercial Officer | Grant | 126K | $0.00 | $0 | 267K |
| 2024-07-08 | DOUG RICE | Chief Financial Officer | Tax withholding | 13K | $6.79 | $87K | 148K |
| 2024-06-05 | PUHY DOROTHY E | Director | Grant | 29K | $7.26 | $210K | 29K |
| 2024-06-05 | Olson Tiffany | Director | Grant | 29K | $7.26 | $210K | 29K |
| 2024-06-05 | HAWKINS WILLIAM A | Director | Grant | 23K | $7.26 | $168K | 175K |
| 2024-06-05 | BEHRENS M KATHLEEN | Director | Grant | 23K | $7.26 | $168K | 184K |
| 2024-06-05 | Newton Todd | Director | Grant | 23K | $7.26 | $168K | 384K |
| 2024-06-05 | BIERMAN JAMES L | Director | Grant | 23K | $7.26 | $168K | 184K |
| 2024-06-05 | LAURENCIN CATO T | Director | Grant | 23K | $7.26 | $168K | 153K |
| 2024-05-08 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $7.20 | $64K | 453K |
| 2024-04-23 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $6.51 | $58K | 462K |
| 2024-04-08 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 9K | $6.90 | $61K | 471K |
| 2024-03-13 | Hulse William Frank IV | General Counsel and CAO | Sell | 20K | $7.95 | $162K | 480K |
| 2024-03-04 | Hulse William Frank IV | General Counsel and CAO | Tax withholding | 15K | $8.26 | $127K | 500K |
| 2024-03-01 | DOUG RICE | Chief Financial Officer | Grant | 58K | $0.00 | $0 | 161K |
| 2024-03-01 | Whitlow Ricci S | Chief Operating Officer | Grant | 58K | $0.00 | $0 | 460K |
| 2024-03-01 | Hulse William Frank IV | General Counsel and CAO | Grant | 59K | $0.00 | $0 | 516K |
| 2024-02-20 | Whitlow Ricci S | Chief Operating Officer | Sell | 15K | $8.01 | $122K | 401K |
| 2024-02-16 | Whitlow Ricci S | Chief Operating Officer | Sell | 15K | $8.07 | $125K | 416K |
| 2024-02-15 | Whitlow Ricci S | Chief Operating Officer | Sell | 15K | $8.06 | $122K | 432K |
| 2024-02-14 | Whitlow Ricci S | Chief Operating Officer | Sell | 16K | $8.03 | $127K | 447K |
| 2023-12-22 | Falcon Fund 2 Holding Company, L.P. | TenPercentOwner | Conversion | 28.2M | price not stated in the filing | not stated | 28.2M |
| 2023-11-21 | DOUG RICE | Chief Financial Officer | Buy | 5K | $7.16 | $36K | 102K |
| 2023-07-05 | DOUG RICE | Chief Financial Officer | Grant | 97K | $0.00 | $0 | 97K |
| 2023-06-23 | Capper Joseph H | Chief Executive Officer | Buy | 42K | $6.50 | $273K | 100K |
| 2023-06-22 | Capper Joseph H | Chief Executive Officer | Buy | 58K | $6.33 | $367K | 58K |
| 2023-06-13 | LAURENCIN CATO T | Director | Grant | 35K | $4.95 | $175K | 130K |
| 2023-06-13 | Newton Todd | Director | Grant | 35K | $4.95 | $175K | 361K |
| 2023-06-13 | HAWKINS WILLIAM A | Director | Grant | 35K | $4.95 | $175K | 152K |
| 2023-06-13 | Giuliani Michael J | Director | Grant | 35K | $4.95 | $175K | 130K |
| 2023-06-13 | GARDNER PHYLLIS | Director | Grant | 35K | $4.95 | $175K | 117K |
| 2023-06-13 | BEHRENS M KATHLEEN | Director | Grant | 35K | $4.95 | $175K | 161K |
| 2023-06-13 | BIERMAN JAMES L | Director | Grant | 35K | $4.95 | $175K | 161K |
| 2023-05-16 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 10K | $5.95 | $62K | 318K |
| 2023-05-15 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 4K | $6.15 | $22K | 328K |
| 2023-05-10 | Carlson Peter M | Chief Financial Officer | Sell | 6K | $5.93 | $35K | 656K |
| 2023-05-10 | Phelan William Lawrence | Chief Accounting Officer | Sell | 2K | $5.93 | $9K | 184K |
| 2023-05-10 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 6K | $5.93 | $35K | 332K |
| 2023-05-10 | Hulse William Frank IV | General Counsel and CAO | Sell | 6K | $5.93 | $35K | 457K |
| 2023-05-04 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 52K | $5.34 | $276K | 338K |
| 2023-05-02 | Phelan William Lawrence | Chief Accounting Officer | Sell | 5K | $3.80 | $20K | 186K |
| 2023-04-25 | Carlson Peter M | Chief Financial Officer | Sell | 6K | $3.74 | $23K | 662K |
| 2023-04-25 | Hulse William Frank IV | General Counsel and CAO | Sell | 6K | $3.74 | $22K | 462K |
| 2023-04-25 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 6K | $3.74 | $22K | 389K |
| 2023-04-25 | Phelan William Lawrence | Chief Accounting Officer | Sell | 2K | $3.74 | $6K | 191K |
| 2023-04-11 | Carlson Peter M | Chief Financial Officer | Sell | 6K | $3.31 | $20K | 669K |
| 2023-04-11 | Hulse William Frank IV | General Counsel and CAO | Sell | 6K | $3.31 | $20K | 468K |
| 2023-04-11 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 6K | $3.31 | $20K | 395K |
| 2023-04-11 | Phelan William Lawrence | Chief Accounting Officer | Sell | 2K | $3.31 | $5K | 193K |
| 2023-03-13 | Hulse William Frank IV | General Counsel and CAO | Grant | 136K | $4.62 | $630K | 474K |
| 2023-03-13 | Phelan William Lawrence | Chief Accounting Officer | Grant | 53K | $4.62 | $245K | 194K |
| 2023-03-13 | Carlson Peter M | Chief Financial Officer | Grant | 140K | $4.62 | $649K | 675K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of MDXG in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-02-13 | 13G/Ano. 1 | Trigran Investments, Inc.investment adviser, corporation | 6.2M | 4.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Douglas T. Granatparent holding company, individual | 6.2M | 4.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Lawrence A. Obermanparent holding company, individual | 6.2M | 4.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Steven G. Simonparent holding company, individual | 6.2M | 4.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Bradley F. Simonparent holding company, individual | 6.2M | 4.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Steven R. Moniesonparent holding company, individual | 6.2M | 4.2% | 2025-12-31 |
13F holders
Tracked managers holding MDXG at their latest 13F. JSON7 of the 30 tracked managers held MDXG at their latest 13F, $26.1M in total at quarter-end prices. AQR Capital Management is the largest at $9.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 2.5M | $9.5M | 0.00% | +1.6M |
| Renaissance Technologies | 2026-06-30 | 2.4M | $9.4M | 0.01% | -576K |
| Citadel Advisors | 2026-06-30 | 826K | $3.2M | 0.00% | +49K |
| D. E. Shaw & Co. | 2026-06-30 | 421K | $1.6M | 0.00% | +109K |
| Two Sigma Investments | 2026-06-30 | 247K | $950K | 0.00% | -21K |
| Fisher Asset Management | 2026-06-30 | 246K | $946K | 0.00% | -810 |
| Point72 Asset Management | 2026-06-30 | 124K | $476K | 0.00% | -91K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Mimedx Group in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Mimedx Group (MDXG), SEC CIK 1376339, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-18.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-02-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1376339Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of MDXG is sold short?
9,362,899 shares were held short at the 2026-09-30 settlement, 7.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is MDXG's daily short volume?
On 2026-10-23, 258,088 of the 454,567 MDXG shares reported to FINRA were sold short, 56.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does MDXG have fails to deliver?
The SEC's latest file shows 600 MDXG shares failed to deliver at settlement 2026-09-18. Fails are reported per settlement date and published twice a month with a lag.
Are MDXG insiders buying or selling?
No open-market insider trades were reported for MDXG in the last 90 days. The most recent filings are listed below. Latest filing: DOUG RICE (Chief Financial Officer) on 2026-07-02.
Who owns 5% or more of MDXG?
No holder on file reports 5% or more of MDXG in its latest filing.
Which tracked 13F managers own MDXG?
7 of the 30 tracked 13F managers held MDXG shares at their latest filing, $26.1M in all. The largest: Cliff Asness's AQR Capital Management (2.5M shares, $9.5M), Renaissance Technologies (2.4M shares, $9.4M), Ken Griffin's Citadel Advisors (826K shares, $3.2M), D. E. Shaw & Co. (421K shares, $1.6M), Two Sigma Investments (247K shares, $950K), Ken Fisher's Fisher Asset Management (246K shares, $946K). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.